Treatment Refractoriness
Treatment Refractoriness is a clinical phenomenon characterized by the failure of a patient's disease or symptom, such as neuropathic pain or ulcerative colitis, to respond adequately to standardized, evidence-based pharmacotherapeutic interventions despite appropriate dosing, duration, and adherence.
158
Publications
7.7K
Citations
1.1K
Authors
461
Institutions
Publications per year
2017–2026
60
Variants
Therapeutic RefractorinessTreatment Resistance
158
Sheldon Preskorn, Bryan Baker, Sheela Kolluri et al. · Journal of Clinical Psychopharmacology · 2008 · 511 citations
At Issue: Defining Treatment Refractoriness in Schizophrenia
H. D. Brenner, S. J. Dencker, Michael J. Goldstein et al. · Schizophrenia Bulletin · 1990 · 246 citations · Full text
1–5 of 158
1.1K
4
h-index
3
h-index
3
h-index
3
h-index
3
h-index
1–5 of 1.1K
461

Icahn School of Medicine at Mount Sinai
New York, United States
5 h-index
19 publications
293 citations
The University of Texas MD Anderson Cancer Center
Houston, United States
4 h-index
16 publications
1.1K citations

Marche Polytechnic University
Ancona, Italy
4 h-index
17 publications
613 citations
University of Pennsylvania
Philadelphia, United States
4 h-index
29 publications
1.4K citations

Children's Hospital of Eastern Ontario
Ottawa, Canada
4 h-index
20 publications
438 citations

Taipei Veterans General Hospital
Taipei, Taiwan
4 h-index
38 publications
4.7K citations
Hospital Clínic de Barcelona
Barcelona, Spain
3 h-index
4 publications
112 citations
University of Pittsburgh
Pittsburgh, United States
3 h-index
7 publications
351 citations
1–8 of 461
Repository · 13 publications · 473 citations
12
h-index
JCC · 4 publications · 89 citations
4
h-index
TCT · 3 publications · 173 citations
3
h-index
3 publications · 221 citations
3
h-index
3 publications · 49 citations
3
h-index
1–5